TORONTO, Feb. 20, 2018 -- Axiom Real-Time Metrics, the premier provider of eClinical solutions and services to small to mid-sized life sciences organizations, is exhibiting at Outsourcing in Clinical Trials West Coast 2018, February 21-22 in Burlingame, California.
“Axiom has an extensive client network on the west coast and we are excited to participate in events such as this, which connect us with leading edge companies to develop new relationships,” expressed Andrew Schachter, CEO and Founder. Axiom invites attendees to join our team for a conversation over coffee at Booth 25.
"Outsourcing is a critical element that must be well managed to achieve success in the life sciences industry, and we are very passionate about playing a key role in our client's technology needs. Our software solutions are relied upon daily by our clients, so their teams can effectively manage their studies, and get products to market faster. We collaborate closely with our clients to develop, design, and launch new features and functionalities that solve key problems. Our product road map includes many innovations that are unique to the market and significantly influenced by client input,” shared Heather Williams, Senior Director of Client Engagement.
Sarah Glofcheskie, Chief Strategy Officer further contributed, "We have deep expertise and excel in meeting the needs of small to mid-sized biotech, pharma, and device companies. We strongly believe that all organizations, irrespective of size, should be working with best-in-class, enterprise-level tools in terms of functionality. A fully unified platform is essential so that your data resides in one spot – it is critical to own your data relationship. Axiom Fusion enables single sign-on to all modules and associated data used in your studies. The ability to tailor a suite based on your needs is key - you choose exactly what you need from our 15 modules and complementary services. Please stop by our booth for a conversation. Our approach is different, and we'd like to show you how."
About Axiom Real-Time Metrics
Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.
CONTACT INFORMATION
Contact
[email protected]
+1.877.321.9191
PR Contact
Sarah Glofcheskie
[email protected]
+1.647.588.9073


Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 



